Is the business good?
How good a business is TFX?
Teleflex Incorporated earns 0.65% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
0.65%
Return on invested capital · cost of capital 9.0% · 8.3 points below what the capital costs: growth destroys value
- Operating margin
- 2.0%
Operating margin · Medical Instruments & Supplies median 5.8% · 12 months to Q2 2026
- Share count, year on year
- −1.5%
Share count, year on year · bought back, each share owns more of the company
- R&D as % of revenue
- 7.1%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2020 | 17% |
| FY2021 | 22% |
| FY2022 | 18% |
| FY2023 | 15% |
| FY2024 | 6.1% |
| FY2025 | 5.9% |
Details›
- Gross margin12 months to Q2 2026
- 55%
- Operating margin12 months to Q2 2026
- 2.0%
- Net margin12 months to Q2 2026
- −46%
- Free cash flow margin
- 7.5%
- R&D as % of revenue
- 7.1%
- Revenue, trailing twelve months
- $2.25B
- Free cash flow, trailing twelve months
- $168M
- Net income, trailing twelve months
- −$1.03B
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 0.65%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Medical Instruments & Supplies
Ranks #12 of 27 by Smart Score